Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Diagnostic source : Www.biospace.com save search
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Published: 2024-03-14 (Crawled : 12:00) - biospace.com/
ZOM | $0.1303 -0.08% 1.15% 1.6M
|
Miscellaneous
|
| O: -4.89%
H: 2.87%
C: 1.66%
test diagnostic publication research platform
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - February 9, 2024
Published: 2024-02-09 (Crawled : 14:30) - biospace.com/
RNLX | $0.829 0.55% 0.54% 120K
|
Technology Services
|
| O: -17.25%
H: 0.0%
C: -14.93%
conference diagnostic life tools
Thermo Fisher Scientific Introduces New Sample Preparation Solutions to Simplify and Automate Respiratory Diagnostic Testing
Published: 2023-12-11 (Crawled : 14:00) - biospace.com/
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
diagnostic respiratory solutions
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
APDN | $0.3295 -4.3% -4.49% 84K
|
Commercial Services
|
| O: 2.27%
H: 4.81%
C: -0.22%
diagnostic cancer dna order application
Natera’s Landmark RenaCARE Study Demonstrates Significant Diagnostic and Clinical Utility of Renasight™ in Chronic Kidney Disease
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
NTRA | $90.33 0.01% 0.01% 680K
|
Health Services
|
| O: 2.12%
H: 2.57%
C: 0.05%
disease diagnostic kidney study
Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Boehringer Ingelheim to Select Patients with NSCLC for Targeted Therapy Treatment
Published: 2023-10-19 (Crawled : 13:30) - biospace.com/
TMO | News | $547.25 -1.32% -0.02% 1.6M
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: 0.0%
diagnostic treatment companion agreement therapy
U.S. Food and Drug Administration (FDA) Approves FoundationOne®CDx as a Companion Diagnostic for Lilly’s Retevmo® (selpercatinib) for Certain Patients with Solid Tumors
Published: 2023-10-09 (Crawled : 18:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: -0.21%
H: 2.8%
C: 1.37%
foundationone drug diagnostic food tumors companion
LABCORP AND BAYSTATE HEALTH ANNOUNCE STRATEGIC RELATIONSHIP FOR DIAGNOSTIC LABORATORY SERVICES
Published: 2023-10-04 (Crawled : 22:00) - biospace.com/
LH M | $199.97 -0.97% 0.0% 680K
|
Health Services
|
| O: 0.02%
H: 0.66%
C: 0.37%
services diagnostic health
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in RomaniaStrategic Collaboration Elevates Early Cancer Detection, Bringing State-of-the-Art Diagnostic Capabilities to Romanian Population
Published: 2023-10-04 (Crawled : 14:00) - biospace.com/
MYNZ | $0.9534 2.02% 23K
|
|
| O: 1.05%
H: 1.72%
C: 1.72%
coloalert diagnostic cancer collaboration
Health Gorilla and Amwell Announce Expanded Digital Diagnostic Lab Ordering for Clinicians
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
AMWL | News | $0.5139 -0.27% 0.0% 3.6M
|
Technology Services
|
| O: -2.63%
H: 8.11%
C: 6.31%
diagnostic health amwell
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of First-and-only Point of Care eACTH Assay for Diagnosis and Management of Cushing’s Disease in Horses
Published: 2023-09-14 (Crawled : 12:00) - biospace.com/
ZOM | $0.1303 -0.08% 1.15% 1.6M
|
Miscellaneous
|
| O: -0.73%
H: 0.28%
C: -3.51%
management disease diagnostic care expansion platform market
AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s Disease
Published: 2023-09-12 (Crawled : 14:30) - biospace.com/
AXIM | $0.0139 -6.67% 230K
|
Manufacturing
|
| O: 11.06%
H: 0.0%
C: -1.53%
axim disease test diagnostic parkinson’s
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations
Published: 2023-09-05 (Crawled : 18:00) - biospace.com/
GH M | $16.4 1.49% 1.46% 1.5M
|
Health Services
|
| O: 0.0%
H: 7.57%
C: 0.86%
guardant360 lung japan diagnostic health her2 approval cancer cell treatment companion
Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion Diagnostic
Published: 2023-08-01 (Crawled : 14:00) - biospace.com/
COEP | $0.3657 -1.16% -1.18% 74K
|
|
| O: -1.63%
H: 4.12%
C: 1.65%
cd38 fda diagnostic companion therapeutics submission in vitro
U.S. Food and Drug Administration (FDA) Approves FoundationOne®Liquid CDx as a Companion Diagnostic for Pfizer’s BRAFTOVI® (encorafenib)
Published: 2023-06-09 (Crawled : 12:00) - biospace.com/
LLY | News | $750.77 0.54% -0.04% 3.1M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: -0.73%
foundationone drug diagnostic food companion
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic TestCompany plans to add multidrug-resistant Candida auris detection to its FDA-cleared T2Candida Panel
Published: 2023-06-05 (Crawled : 13:20) - biospace.com/
TTOO A | $2.94 -2.97% -3.06% 62K
|
Health Technology
|
| O: 35.78%
H: 6.14%
C: -49.46%
fda device diagnostic biosystems designation submission
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Published: 2023-04-11 (Crawled : 15:00) - biospace.com/
AXIM | $0.0139 -6.67% 230K
|
Manufacturing
|
| O: -1.41%
H: 57.14%
C: 23.57%
axim diagnostic ocular commercial
Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development
Published: 2023-04-11 (Crawled : 12:00) - biospace.com/
BMY | $47.84 -0.87% -0.02% 12M
|
Health Technology
|
| O: 0.27%
H: 0.04%
C: -0.62%
partnership diagnostic companion
New Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients
Published: 2023-03-23 (Crawled : 15:00) - biospace.com/
DXR | $9.551 0.73% 850
|
Health Technology
|
| O: -3.82%
H: 2.74%
C: 2.58%
bva-100 100 diagnostic unique heart study
Pilot Randomized Controlled Trial Validates Daxor BVA-100® Diagnostic for Heart Failure Patients
Published: 2023-03-23 (Crawled : 13:00) - biospace.com/
DXR | $9.551 0.73% 850
|
Health Technology
|
| O: -3.82%
H: 2.74%
C: 2.58%
bva-100 100 diagnostic heart trial pilot
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.